Due to the sequestration cuts and the government shutdown, the US Food and Drug Administration has lost out on some $85 million in user fees, MassDevice reports, adding that that number may climb higher. The White House Office of Management and Budget crunched the numbers in response to a request from Representative Anna Eshoo (D-Calif.).
MassDevice notes that the cuts are to continue and that the user fees collected are placed into an account FDA cannot touch until Congress appropriates them
FDA collects user fees from medical device and pharmaceutical companies that helps the agency pay for the review of new products. This loss of fees, MassDevice adds, may make it difficult for the agency to carry out the reviews it needs to, especially as it has also lost $210 million from its 2013 budget as part of the sequestration cuts.